Novo Holdings, Glenview Capital and b2venture led the Series E round, which will fund commercial expansion in the US.

Quanta Dialysis Technologies
Quanta Dialysis Technologies provides compact dialysis systems for clinical and home use.
Quanta Dialysis Technologies develops the compact Quanta Dialysis System to make kidney care accessible across multiple clinical and home settings. The firm received the MacRobert Award for engineering innovation in 2022.
Categories
Team

John Milad
CEO
John brings life sciences, venture capital, and operational experience from roles including chief executive officer at ERS Genomics and Quanta Dialysis Technologies, alongside venture investing at Downing LLP.
LinkedInJohan de Ruiter
Chairman
Johan brings life sciences and medtech experience as an entrepreneur, investor, and non-executive board member. He holds chairmanships at Quanta Dialysis Technologies and the CHT Group, alongside supervisory and advisory roles across healthcare and technology businesses.
LinkedInAlejandro Galindo
Chief Executive Officer
Investors
- £47.4M
- £175M
Funding history
The financing round was led by Glenview Capital and co-led by Novo Holdings.